Clinical outcome after 36 months of treatment with injections of autologous blood for recurrent dislocation of the temporomandibular joint |
| |
Authors: | H Yoshida Y-i Nakatani S Gamoh K Shimizutani S Morita |
| |
Institution: | 1. First Department of Oral and Maxillofacial Surgery, Osaka Dental University;2. Department of Oral Radiology, Osaka Dental University |
| |
Abstract: | We investigated the prognosis after three years of treatment for recurrent dislocation of the temporomandibular joint with autologous blood given intravenously in 21 patients with a mean (range) age 64 (17-92) years of whom 16 had coexisting systemic disease. The mean (range) follow up from the first injection was 64 (41-99) months. Eighteen patients had no recurrence during the first 36 months after their first injection, which showed that this minimally-invasive treatment was effective, particularly for those who had conditions that made a mouthpiece or operation unsuitable. |
| |
Keywords: | blood outpatient recurrent TMJ dislocation Autologous blood injection (ABI) |
本文献已被 ScienceDirect 等数据库收录! |